A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Clinical trial NCT01737359 · TERMINATED

Trial details

NCT number: NCT01737359
Sponsor: RFS Pharma, LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Infection

Start date: 2012-12-01
Primary completion: 2013-02-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.